Girma Gilano | Health Professions | Best Researcher Award

Posted on by ScienceFather

Mr. Girma Gilano | Health Professions | Best Researcher Award Teacher of UESPI, Brazil.

Assistant prof. and PhD candidate at Arba Minch University, Ethiopia

Mr. Girma Gilano Kaso is an experienced Senior Researcher at Arba Minch University with a focus on public health informatics. He is currently pursuing a PhD at Maastricht University, specializing in digital health solutions and data management. His professional experience includes leading significant projects like digitalizing chronic disease management and enhancing health data quality. Mr. Kaso has a strong background in research, demonstrated by his work on mHealth impacts and systematic reviews. He has received recognition for his achievements in improving health management systems and has been actively involved in various organizational roles, including quality coordination and research leadership. His multilingual skills and professional memberships further enhance his contributions to the field.

Professional Profiles:

Education

Mr. Girma Gilano Kaso is currently pursuing a PhD at Maastricht University, Netherlands, focusing on radiography under Professor Andre Dekker (April 2022 – Present). He holds a Master’s degree in Public Health Informatics from the University of Gondar, Ethiopia (September 2009 – June 2012), where he was guided by Attinkut Alamirrew. His undergraduate studies were completed at Jimma University, Ethiopia, where he earned a BSc in General Nursing (September 2003 – June 2007) under the supervision of Bosana Tebeje.

Professional Experience

Mr. Girma Gilano Kaso is a Senior Researcher at Arba Minch University, Ethiopia, focusing on public health informatics since April 2017. Previously, he served as a Senior Researcher at Arba Minch College of Health Sciences from November 2009 to March 2017. During this time, he led impactful projects such as “Digitalizing Chronic Disease at Arba Minch General Hospital” (2018-2022) and improved Health Management Information System (HMIS) data quality in Southern Ethiopia (2020-2022). He also held significant roles including Clinical Department Head (2009-2011), Research Coordinator (2015-2017), and Institutional Quality Coordinator at Arba Minch University (2019-2022).

Research Interest

Mr. Girma Gilano Kaso specializes in public health informatics, focusing on digital health solutions and their impact on healthcare systems. His research includes evaluating the effectiveness of mHealth technologies on childhood vaccination and feeding practices in Africa. He is also interested in improving Health Management Information Systems (HMIS) to enhance data quality and information use. His work aims to integrate digital tools into healthcare settings to address chronic diseases and optimize health information systems.

 Award and Honors

Mr. Girma Gilano Kaso has achieved significant milestones in his career, notably leading a successful project on “Digitalizing Chronic Disease” at Arba Minch General Hospital, which was completed over four years (2018-2022). He has also contributed to the improvement of HMIS data quality in Southern Ethiopia. His notable reviews include systematic analyses of mHealth impacts on childhood vaccination and feeding practices in Africa. His work has earned him recognition in the field of public health informatics, showcasing his dedication to enhancing healthcare through innovative digital solutions.

Research Skills

Mr. Girma Gilano Kaso possesses extensive research skills in public health informatics, particularly in digital health and data management. His expertise includes leading and implementing projects focused on digitalizing chronic disease management and improving health management information systems. He has conducted systematic reviews and meta-analyses on mHealth impacts on vaccination and feeding practices in Africa. Proficient in utilizing various research methodologies, he combines strong analytical abilities with hands-on experience in health data quality improvement and digital health solutions. His contributions reflect a solid understanding of both theoretical and practical aspects of public health informatics.

Publications

  1. “Effect of mobile phone messaging on uptake of maternal and child health service in southern Ethiopia: Protocol for cluster randomized controlled trial”
    • Authors: Gilano, G., Dekker, A., Fijten, R.
    • Year: 2024
    • Journal: Clinical Nutrition Open Science
    • Volume: 54
    • Pages: 89–99
  2. “The effect of mHealth on childhood vaccination in Africa: A systematic review and meta-analysis”
    • Authors: Gilano, G., Sako, S., Molla, B., Dekker, A., Fijten, R.
    • Year: 2024
    • Journal: PLoS ONE
    • Volume: 19(2)
    • Article ID: e0294442
  3. “The role of mHealth intervention to improve maternal and child health: A provider-based qualitative study in Southern Ethiopia”
    • Authors: Gilano, G., Dekker, A., Fijten, R.
    • Year: 2024
    • Journal: PLoS ONE
    • Volume: 19(2)
    • Article ID: e0295539
  4. “Assessing the effect of mHealth on child feeding practice in African countries: systematic and meta-analysis”
    • Authors: Gilano, G., Sako, S., Dileba, T., Dekker, A., Fijten, R.
    • Year: 2023
    • Journal: Journal of Health, Population and Nutrition
    • Volume: 42(1)
    • Page: 138
  5. “Individual and community-level factors associated with introducing prelacteal feeding in Ethiopia”
    • Authors: Gilano, G., Hailegebreal, S., Kashala, K., Gilano, K.
    • Year: 2023
    • Journal: Clinical Nutrition Open Science
    • Volume: 52
    • Pages: 14–24
  6. “Satisfaction of health informatics professionals with Ethiopian health system: the case of three zones in Ethiopia”
    • Authors: Gilano, G., Sako, S., Boranto, B., Haile, F., Hassen, H.
    • Year: 2023
    • Journal: BMC Health Services Research
    • Volume: 23(1)
    • Article ID: 615
  7. “Determinants of childhood vaccination among children aged 12-23 months in Ethiopia: a community-based cross-sectional study”
    • Authors: Sako, S., Gilano, G., Hailegebreal, S.
    • Year: 2023
    • Journal: BMJ Open
    • Volume: 13(3)
    • Article ID: e069278
  8. “Modern contraceptive use and associated factors among reproductive-age women in Ethiopia: multilevel analysis evidence from 2019 Ethiopia mini demographic and health survey”
    • Authors: Hailegebreal, S., Dileba Kale, T., Gilano, G., Haile, Y., Endale Simegn, A.
    • Year: 2023
    • Journal: Journal of Maternal-Fetal and Neonatal Medicine
    • Volume: 36(2)
    • Article ID: 2234067
  9. “Understanding the association of mass media with the timing of antenatal care in Ethiopia: an impression from the 2016 Ethiopia demographic and health survey”
    • Authors: Gilano, G., Hailegebreal, S., Sako, S., Seboka, B.T.
    • Year: 2023
    • Journal: Journal of Maternal-Fetal and Neonatal Medicine
    • Volume: 36(1)
    • Article ID: 2183760
  10. “Understanding Child Wasting in Ethiopia: Cross-sectional Analysis of 2019 Ethiopian Demographic and Health Survey Data Using Generalized Linear Latent and Mixed Models”
    • Authors: Gilano, G., Hailegebreal, S., Sako, S., Seboka, B.T., Kashala, K.
    • Year: 2023
    • Journal: JMIR Public Health and Surveillance
    • Volume: 9
    • Article ID: e39744

AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. AKHILESHWAR NAMANI | Medicine and Dentistry | Best Researcher Award

Scientist at Sri Shankara Cancer Hospital and Research Centre, India.

Dr. Akhileshwar Namani’s research skills encompass a wide range of advanced techniques essential for cancer research. He is adept in molecular biology techniques such as DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani is also skilled in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His expertise extends to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. Additionally, he is experienced in conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach, combining molecular biology, genetics, and bioinformatics, enables him to contribute significantly to understanding cancer mechanisms and developing novel therapeutic strategies.

Professional Profiles:

Education

Dr. Akhileshwar Namani completed his Ph.D. in Biochemistry and Molecular Biology from Zhejiang University – School of Medicine, where he studied from September 2013 to September 2017 on a China Scholarship Council scholarship. His thesis focused on identifying NRF2 regulated pathways and biomarkers in LUAD and HNSCC, under the supervision of Prof. Tang Xiuwen. Prior to his doctoral studies, he earned his M.Sc. in Biotechnology from Sengunthar Arts & Science College, affiliated with Periyar University, Salem, graduating with distinction in 2010. Dr. Namani’s academic journey began with a B.Sc. in Biotechnology, Zoology, and Chemistry from Vaagdevi Degree & P.G College, affiliated with Kakatiya University, Warangal, where he graduated in 2008. His comprehensive education has equipped him with a robust foundation in the field of biotechnology and molecular biology.

Professional Experience

Dr. Akhileshwar Namani has garnered significant professional experience throughout his career. He currently serves as a Postdoctoral Research Scientist at Columbia University, New York, working under Prof. Wei Gu since January 2020. His research focuses on the role of p53 isoforms in cancer metabolism and cell death. Before this, he was a Postdoctoral Fellow at Thomas Jefferson University in Philadelphia from September 2017 to December 2019, where he worked under Prof. Garth L. Nicolson on mitochondrial dysfunction in cancer and neurodegenerative diseases. During his Ph.D. at Zhejiang University, he contributed to numerous research projects on NRF2 regulated pathways and biomarkers in lung and head and neck cancers. Additionally, Dr. Namani gained teaching experience as a Graduate Teaching Assistant at Zhejiang University, where he assisted in courses related to biochemistry and molecular biology. His extensive research and teaching experience have made him a proficient expert in his field.

Research Interest

Dr. Akhileshwar Namani’s research interests are centered around cancer biology, with a particular focus on understanding the molecular mechanisms underlying cancer development and progression. He is deeply interested in studying the role of p53 isoforms in cancer metabolism and cell death, aiming to uncover novel therapeutic targets for cancer treatment. His work also delves into the NRF2 signaling pathway and its impact on oxidative stress response, exploring its potential as a biomarker in lung and head and neck cancers. Additionally, Dr. Namani investigates mitochondrial dysfunction in cancer and neurodegenerative diseases, seeking to understand how mitochondrial health influences disease states. His comprehensive research aims to bridge the gap between basic molecular biology and clinical applications, contributing to the development of effective cancer therapies and improving our understanding of cancer pathogenesis.

Award and Honors

Dr. Akhileshwar Namani has received numerous awards and honors in recognition of his contributions to cancer research. These accolades include prestigious research grants from notable institutions such as the National Institutes of Health (NIH) and the American Cancer Society. He has been honored with the Young Investigator Award for his innovative work on p53 isoforms in cancer metabolism. Additionally, Dr. Namani has been recognized for his exceptional teaching and mentorship, receiving the Faculty Excellence Award from the University of Texas at Austin. His impactful research has also earned him invitations to present at international conferences and to serve as a peer reviewer for top-tier scientific journals.

Research Skills

Dr. Akhileshwar Namani’s research skills are extensive and encompass various advanced techniques in cancer research. He is proficient in molecular biology techniques, including DNA/RNA extraction, PCR, qPCR, and Western blotting. Dr. Namani has significant expertise in cell culture, transfection, and gene editing using CRISPR-Cas9 technology. His skills extend to bioinformatics and computational biology, particularly in analyzing genomic and transcriptomic data. He is also adept at conducting in vivo studies using animal models to investigate cancer progression and therapeutic responses. Dr. Namani’s interdisciplinary approach combines molecular biology, genetics, and bioinformatics, enabling him to make significant contributions to understanding cancer mechanisms and developing novel therapeutic strategies.

Publications

  1. Nrf2 signaling pathway: Pivotal roles in inflammation
    1. Authors: SMU Ahmed, L Luo, A Namani, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease
    3. Year: 2017
    4. Citations: 1588
  2. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer
    1. Authors: A Namani, Y Li, XJ Wang, X Tang
    2. Journal: Biochimica et Biophysica Acta (BBA) – Molecular Cell Research
    3. Year: 2014
    4. Citations: 139
  3. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer
    1. Authors: A Namani, M Matiur Rahaman, M Chen, X Tang
    2. Journal: BMC Cancer
    3. Year: 2018
    4. Citations: 91
  4. Nrf2: bane or blessing in cancer?
    1. Authors: MJ Xiang, A Namani, SJ Wu, XL Wang
    2. Journal: Journal of Cancer Research and Clinical Oncology
    3. Year: 2014
    4. Citations: 75
  5. “NRF2 addiction” in lung cancer cells and its impact on cancer therapy
    1. Authors: A Hammad, A Namani, M Elshaer, XJ Wang, X Tang
    2. Journal: Cancer Letters
    3. Year: 2019
    4. Citations: 63
  6. Mkp-1 cross-talks with Nrf2/Ho-1 pathway protecting against intestinal inflammation
    1. Authors: J Li, H Wang, Z Zheng, L Luo, P Wang, K Liu, A Namani, Z Jiang
    2. Journal: Free Radical Biology and Medicine
    3. Year: 2018
    4. Citations: 60
  7. NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer
    1. Authors: A Namani, QQ Cui, Y Wu, H Wang, XJ Wang, X Tang
    2. Journal: Oncotarget
    3. Year: 2017
    4. Citations: 47
  8. Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways
    1. Authors: A Namani, K Liu, S Wang, X Zhou, Y Liao, H Wang, XJ Wang, X Tang
    2. Journal: Aging (Albany NY)
    3. Year: 2019
    4. Citations: 27
  9. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice
    1. Authors: A Hammad, ZH Zheng, Y Gao, A Namani, HF Shi, X Tang
    2. Journal: Life Sciences
    3. Year: 2019
    4. Citations: 19
  10. Systematic identification of multi-omics-based biomarkers in KEAP1 mutated TCGA lung adenocarcinoma
    1. Authors: A Namani, Z Zheng, XJ Wang, X Tang
    2. Journal: Journal of Cancer
    3. Year: 2019
    4. Citations: 11